In the BioHarmony Drug Report Database

"Preview" Icon

Homatropine

Hydrocodone Bitartrate and Homatropine Methylbromide, NutropinAq (homatropine) is a small molecule pharmaceutical. Homatropine was first approved as Hydrocodone Bitartrate and Homatropine Methylbromide on 2001-02-15. It is used to treat inflammation in the USA. It has been approved in Europe to treat pituitary dwarfism, prader-willi syndrome, and turner syndrome.

 

Trade Name

 

NutropinAq
 

Common Name

 

homatropine
 

ChEMBL ID

 

CHEMBL1618018
 

Indication

 

inflammation, pituitary dwarfism, prader-willi syndrome, turner syndrome
 

Drug Class

 

Atropine derivatives

Image (chem structure or protein)

Homatropine structure rendering